Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Acta Diabetologica|December 26, 2014
Long-term effects of baroreflex activation therapy on glucose metabolismManuel Wallbach, Luca-Yves Lehnig, Hans-Joachim Helms, et al.Journal of Clinical Medicine|February 11, 2023
Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant HypertensionAnn-Kathrin C Schäfer, Dennis Pieper, Hassan Dihazi, et al.Hypertension (Dallas, Tex. : 1979)|February 24, 2016
Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant HypertensionManuel Wallbach, Luca-Yves Lehnig, Charlotte Schroer, et al.Clinical Kidney Journal|September 11, 2024
Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonographyManuel Wallbach, Jamil Ajrab, Bilgin Bayram, et al.Kidney Medicine|June 30, 2026
Effects of SGLT2I Therapy on Tubular Reabsorption and Tubular Epithelial Stress Injury in Patients With CKDAnn-Kathrin C Schäfer, Dennis Pieper, Bilgin Bayram, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|June 8, 2021
Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertensionAnn-Kathrin Schäfer, Tim Kuczera, Rebecca Wurm-Kuczera, et al.Clinical Rheumatology|October 14, 2016
The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic diseaseCarsten Paul Bramlage, Britta Froelich, Manuel Wallbach, et al.ESC Heart Failure|July 6, 2024
Effects of baroreflex activation therapy on cardiac function and morphologyAnn-Kathrin C Schäfer, Manuel Wallbach, Charlotte Schroer, et al.Rheumatology International|February 20, 2017
Urinary free light chains may help to identify infection in patients with elevated systemic inflammation due to rheumatic diseaseCarsten P Bramlage, Britta Froelich, Manuel Wallbach, et al.Journal of Hypertension|April 21, 2018
Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertensionManuel Wallbach, Enrico Böhning, Luca-Yves Lehnig, et al.Pageof 5